CN101370524A - 脂肽组合物 - Google Patents
脂肽组合物 Download PDFInfo
- Publication number
- CN101370524A CN101370524A CNA2006800511655A CN200680051165A CN101370524A CN 101370524 A CN101370524 A CN 101370524A CN A2006800511655 A CNA2006800511655 A CN A2006800511655A CN 200680051165 A CN200680051165 A CN 200680051165A CN 101370524 A CN101370524 A CN 101370524A
- Authority
- CN
- China
- Prior art keywords
- cyclodextrin
- lipopeptid
- derivant
- weight
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005056194A DE102005056194A1 (de) | 2005-11-21 | 2005-11-21 | Neue Lipopeptid Zusammensetzungen |
DE102005056194.2 | 2005-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101370524A true CN101370524A (zh) | 2009-02-18 |
Family
ID=37763891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006800511655A Pending CN101370524A (zh) | 2005-11-21 | 2006-11-20 | 脂肽组合物 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1951311A1 (de) |
CN (1) | CN101370524A (de) |
AU (1) | AU2006314942A1 (de) |
CA (1) | CA2630497A1 (de) |
DE (1) | DE102005056194A1 (de) |
MX (1) | MX2008006476A (de) |
WO (1) | WO2007057005A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104768966A (zh) * | 2012-09-24 | 2015-07-08 | 中化帝斯曼制药有限公司荷兰公司 | 生产环肽的方法 |
CN113811290A (zh) * | 2019-05-10 | 2021-12-17 | 埃克斯利亚制药有限公司 | 达托霉素水性制剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411025A1 (de) * | 1994-03-30 | 1995-10-05 | Hoechst Ag | Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
DE19807972A1 (de) * | 1998-02-25 | 1999-08-26 | Hoechst Marion Roussel De Gmbh | Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung |
JP4870314B2 (ja) * | 2000-05-02 | 2012-02-08 | セラヴァンス, インコーポレーテッド | シクロデキストリンを含むグリコペプチド抗生物質組成物 |
US7527807B2 (en) * | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
UA82824C2 (uk) * | 2000-06-21 | 2008-05-26 | К'Юбіст Фармасьютікалз, Інк. | Композиція і спосіб поліпшення перорального всмоктування протимікробних засобів |
WO2002032459A2 (en) * | 2000-10-17 | 2002-04-25 | Massachusetts Institute Of Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
-
2005
- 2005-11-21 DE DE102005056194A patent/DE102005056194A1/de not_active Ceased
-
2006
- 2006-11-20 AU AU2006314942A patent/AU2006314942A1/en not_active Abandoned
- 2006-11-20 CA CA002630497A patent/CA2630497A1/en not_active Abandoned
- 2006-11-20 WO PCT/DE2006/002064 patent/WO2007057005A1/de active Application Filing
- 2006-11-20 CN CNA2006800511655A patent/CN101370524A/zh active Pending
- 2006-11-20 MX MX2008006476A patent/MX2008006476A/es not_active Application Discontinuation
- 2006-11-20 EP EP06805527A patent/EP1951311A1/de not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104768966A (zh) * | 2012-09-24 | 2015-07-08 | 中化帝斯曼制药有限公司荷兰公司 | 生产环肽的方法 |
CN104768966B (zh) * | 2012-09-24 | 2018-11-02 | 中化帝斯曼制药有限公司荷兰公司 | 生产环肽的方法 |
CN113811290A (zh) * | 2019-05-10 | 2021-12-17 | 埃克斯利亚制药有限公司 | 达托霉素水性制剂 |
Also Published As
Publication number | Publication date |
---|---|
WO2007057005A1 (de) | 2007-05-24 |
CA2630497A1 (en) | 2007-05-24 |
AU2006314942A1 (en) | 2007-05-24 |
EP1951311A1 (de) | 2008-08-06 |
DE102005056194A1 (de) | 2007-07-12 |
MX2008006476A (es) | 2008-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2062582B1 (de) | Antibiotische zusammensetzung mit beta-lactam-antibiotika, aminoglykosiden und puffern | |
US4767874A (en) | Stable freeze-dried preparations of an anticancer platinum complex | |
RU2734236C2 (ru) | Композиции бендамустина и циклополисахарида | |
CA2668733C (en) | Liquid preparation comprising a complex of pimobendan and cyclodextrin | |
AU742036B2 (en) | Pharmaceutical compositions containing cyclodextrins and taxoids | |
EP0091782B1 (de) | Einschlussverbindung von Antibiotika der Lankacidingruppe sowie deren Verwendung | |
KR19990064137A (ko) | 경구투여용 항균성 조성물 | |
KR20010034240A (ko) | 약학 조성물 | |
FR2596651A1 (fr) | Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant | |
TWI246926B (en) | Pharmaceutical dronedarone composition for parenteral administration | |
KR100700963B1 (ko) | 켐토테신의 다당체 유도체를 함유하는 동결건조된 액상제제 | |
PT2047857E (pt) | Agente para fins de injecção compreendendo um antibióitco, e solução para injecção compreendendo o agente | |
US7795207B2 (en) | Lipopeptide compositions | |
CA2389304A1 (en) | Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing | |
FR2499854A1 (fr) | Medicament contenant de la cyclodextrine utile notamment pour provoquer la proliferation des bifidobacteries intestinales | |
CN101370524A (zh) | 脂肽组合物 | |
JPH0764884B2 (ja) | シクロデキストリン組成物 | |
JP3597239B2 (ja) | 安定な点眼剤 | |
US20040157797A1 (en) | Drug formulation and delivery using crystalline methylated cyclodextrins | |
JP2000509013A (ja) | ウルソデオキシコール酸またはタウロウルソデオキシコール酸、強塩基、およびトロメタモールを含む注射可能な薬学的組成物 | |
CA2486571C (en) | Pharmaceutical composition | |
EP1994938A1 (de) | Neue Lipoglycodepsipeptid-Zusammensetzungen | |
KR20090069264A (ko) | 주사 투여용 약제학적 조성물 | |
JP2002542201A (ja) | シュードマイシン抗真菌組成物およびその使用方法 | |
RU2800287C1 (ru) | Антибактериальная композиция грамицидина с, способ ее получения и применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090218 |